Search Results
22 items found for "malignant melanoma"
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
September 2022 GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response Functional studies showed that GASP1 knockout significantly suppressed malignant properties of breast stimulated GASP1 expression by activating the PI3K/AKT pathway, forming a vicious cycle propelling the malignant Collectively, this study demonstrates that GASP1 enhances malignant behaviors of breast cancer cells
- CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...
September 2022 CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma However, the effect of CCR9 on salivary adenoid cystic carcinoma (SACC) malignant behavior remains unknown This study aimed to investigate the specific molecular mechanism by which CCR9/CCL25 modulates malignant
- MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
Additionally, CXCR4 is expressed by tumor cells in blood malignancies and solid tumors."
- Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell...
target " Purpose: Beta 2-Adrenergic Receptor (β2-AR) is significantly overexpressed in various types of malignancies
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
chemicals, hormones, cytokines, and, recently, gene editing techniques, have been tested to reduce the malignancy
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
(PAR), a subgroup of GPCRs, form a family of four members (PAR1-4) centrally involved in epithelial malignancies
- Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its...
transport, tooth eruption, bone formation and bone remodeling, and causes hypercalcemia in patients with malignancy
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
Glioma is the most common adult malignant brain tumor and requires novel therapeutic strategies to improve
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
GTPase activity and result in constitutive signaling, as occurs with the αqQ209L mutation in uveal melanoma
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
in situ visualization and quantification of SST2/SST5 dimerization in rat GH3 as well as in human melanoma
- 📰 GPCR Weekly News, September 11 to 17, 2023
immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
- Chemokine receptor-targeted drug discovery: progress and challenges
responses and a comprehensive understanding of the role of the chemokine receptor system in different malignancies
- 📰 GPCR Weekly News
GPR4 in the pH-dependent migration of melanoma cells in the tumor microenvironment.
- Fusion protein strategies for cryo-EM study of G protein-coupled receptors
challenging because most receptors lack structural features in their soluble domains to facilitate image alignment
- The Gluopsins: Opsins without the Retinal Binding Lysine
The pipeline compiles and aligns sequences from public sources, reconstructs the phylogeny, prunes rogue
- Functional molecular switches of mammalian G protein-coupled bitter-taste receptors
existing experimental data in the literature as constraints, we pinpointed conserved motifs to entirely re-align
- Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use of...
The predicted models were then aligned with the experimentally solved structures and evaluated by the
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
dose- and frequency-dependent manner, and triggered the formation of cell condensations that developed aligned
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
GPCR molecular dynamics forecasting using recurrent neural networks A method for multiple-sequence-alignment-free
- Overview of adhesion GPCRs self-activation
Furthermore, when an alignment analysis of the Stalk peptide of the aGPCR family was performed highlighted
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
major bottleneck requiring extensive experimental datasets and in vivo validation which does not always align
- Structural landscape of the Chemokine Receptor system
comparing the CKRs structures complexes, the disulfide bridges formed between the N-loop and the β3-strand align